IMUX Immunic
- 1.261
- -0.029-2.22%
Immunic News
Immunic | 10-Q: Quarterly report
Immunic | 8-K: Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update
Immunic | EFFECT: Others
Immunic | 424B3: Prospectus
Immunic | DEF 14A: Definitive information statements
Immunic | 8-K: Poll Results of Special Meeting
Immunic | 4: Statement of changes in beneficial ownership of securities-Director HOWSON TAMAR D
Immunic | 4: Statement of changes in beneficial ownership of securities-Officer Nash Duane
Immunic | 4: Statement of changes in beneficial ownership of securities-Director PHILLIPS BARCLAY A
Immunic | 4: Statement of changes in beneficial ownership of securities-Officer Vitt Daniel
Immunic | 4: Statement of changes in beneficial ownership of securities-Officer Muehler Andreas
Immunic | 4: Statement of changes in beneficial ownership of securities-Officer Whaley Glenn
Immunic | 4: Statement of changes in beneficial ownership of securities-Director Neermann Joerg
Immunic | 4: Statement of changes in beneficial ownership of securities-Director Toernsen Monika Maria
Immunic | S-3/A: Registration statement for specified transactions by certain issuers (Amendment)
Immunic | 4: Statement of changes in beneficial ownership of securities-Officer Vitt Daniel
Immunic | 10-K: Annual report
Immunic | 8-K: Immunic, Inc. Reports Year End 2023 Financial Results and Provides Corporate Update
Immunic | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Commodore Capital LP(0.0%),Commodore Capital Master LP(0.0%)
Immunic | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(0%),Deep Track Biotechnology Master Fund, Ltd.(0%), etc.
Analysis
Price Target
No Data
